Nonchromosomal, nonsyndromic holoprosencephaly (NCNS-HPE) has traditionally been considered as a condition of brain and craniofacial maldevelopment. In this review, we present the results of a comprehensive literature search supporting a wide spectrum of extracephalic manifestations identified in patients with NCNS-HPE. These manifestations have been described in case reports and in large cohorts of patients with "single-gene" mutations, suggesting that the NCNS-HPE phenotype can be more complex than traditionally thought. Likely, a complex network of interacting genetic variants and environmental factors is responsible for these systemic abnormalities that deviate from the usual brain and craniofacial findings in NCNS-HPE. In addition to the systemic consequences of pituitary dysfunction (as a direct result of brain midline defects), here we describe a number of extracephalic findings of NCNS-HPE affecting various organ systems. It is our goal to provide a guide of extracephalic features for clinicians given the important clinical implications of these manifestations for the management and care of patients with HPE and their mutation-positive relatives. The health risks associated with some manifestations (e.g., fatty liver disease) may have historically been neglected in affected families.
| I N TR ODU C TI ON
Holoprosencephaly (HPE, MIM 236100) is a common malformation of the human brain caused by incomplete midline separation of the developing prosencephalon (Roessler et al., 1996) . HPE affects 1 in 250 conceptuses, of which less than 1 in 10,000 reach full-term pregnancy and only 1 in 100,000 live past the first year (Orioli & Castilla, 2010) .
The etiology of HPE is complex, with both genetic and environmental factors implicated (M. M. Cohen & Shiota, 2002; Heyne et al., 2016; Lipinski, Godin, O'Leary-Moore, Parnell, & Sulik, 2010; Muenke & Beachy, 2000) . Approximately 25% of patients with HPE comprise monogenic syndromes and 40-50% harbor a chromosomal aberration (Dubourg et al., 2007; Solomon, Gropman, & Muenke, 2013) . Analysis of recurrent chromosomal anomalies led to the identification of the first genes implicated in HPE, which participate in key developmental signaling networks such as Sonic hedgehog (SHH), bone morphogenetic protein (BMP), fibroblast growth factor (FGF), wingless/integrated (WNT), Nodal, and retinoid (Petryk, Graf, & Marcucio, 2015; Roessler & Muenke, 1998) . Mutations in the SHH gene are the most common cause of nonchromosomal, nonsyndromic HPE (NCNS-HPE) in humans (Nanni et al., 1999; Roessler et al., 1996; Solomon et al., 2012 ) and many of the HPE genes encode proteins that appear to either directly or indirectly regulate SHH expression or signaling (Petryk et al., 2015; Taniguchi, Anderson, Sutherland, & Wotton, 2012) . To date, a total of lobar (DeMyer, 1987) . Alobar HPE is characterized by complete or almost complete interhemispheric fusion, a single ventricle, typically absent olfactory bulbs and corpus callosum, and severe facial features such as synophthalmia (cyclopia) and proboscis. In semilobar HPE, there is partial cortical separation posteriorly, a single ventricle, and absent or hypoplastic corpus callosum. In lobar HPE, the ventricles are separated, but there is incomplete separation of the frontal lobes, especially ventrally. In the rare lobar subtype, septopreoptic HPE, the midline fusion is limited to the septal and/or preoptic regions of the telencephalon without a significant frontorostral fusion (Hahn, Barnes, Clegg, & Stashinko, 2010) . A milder form called middle interhemispheric variant has also been characterized, in which the posterior frontal and parietal lobes fail to separate and the corpus callosum may be hypoplastic . At the mildest end of the spectrum, microform HPE describes individuals with subtle craniofacial anomalies, such as a single maxillary central incisor, hypotelorism, eye coloboma, narrow nasal bridge, etc., in the absence of typical brain malformations, at least at the level that can be detected by conventional neuroimaging Solomon et al., 2009) .
While chromosomal or syndromic HPE can cause malformations of multiple body systems, NCNS-HPE has traditionally been considered as an "above-the-neck" condition. However, a number of extracephalic manifestations have been described over the years in NCNS-HPE that can be present in a significant proportion of patients, accounting for the complexity of genetic and environmental interactions responsible for the HPE phenotype.
| T HE H ED GE HO G P A THWA Y I N D E VE LOP M E NT
The hedgehog (Hh) pathway is evolutionarily conserved from Drosophila to superior vertebrates. Hh ligands act as key mediators in fundamental cellular processes of embryonic development, acting as morphogens that promote dose-dependent induction differentiation and determining cell fates. They also have mitogenic effects, controlling cell proliferation, survival, and organogenesis in different anatomical regions of the body. In particular, SHH serves as an induction signal of the ventral neural tube to promote development of the anteriorposterior axis of extremities and somatic ventral structures (Ingham & McMahon, 2001; Ruat, Roudaut, Ferent, & Traiffort, 2012) .
| Endocrine glands
Hh signaling participates actively in the development of endocrine glands: pituitary, ovary, testis, adrenal cortex, pancreas, and prostate (for reviews see M. M. Cohen, 2010; P. J. King, Guasti, & Laufer, 2008) .
In addition to SHH, there are two other vertebrate Hh ligands: Indian hedgehog (IHH) and Desert hedgehog (DHH) (M. M. Cohen, 2003) , each with a specific developmental expression pattern and function.
SHH is expressed in the neural tube, IHH in the cartilaginous growth zone, and DHH is mostly restricted to the gonads, including Sertoli cells in the testes and granulosa cells in the ovaries (M. M. Cohen, 2010; Varjosalo & Taipale, 2008) . In HPE, reports of endocrine dysfunction have been limited to the pituitary, adrenal, and thyroid glands (Table 1) .
Although the adrenal and thyroid dysfunctions are thought to be the result of abnormal pituitary secretions, here we also discuss the role of Hh signaling in the development of these two glands.
| Pituitary gland
Pituitary formation begins with an invagination of the anterior pituitary placode within the oral ectoderm to form Rathke's pouch, the primordium of the gland. The dorsal region of this structure makes direct contact with a region of the ventral diencephalon, the infundibulum, and this interaction, along with regions within Rathke's pouch and the surrounding mesenchyme, is required for the specification of pituitary endocrine cell types from progenitor cells within the pouch (P. J. King et al., 2008; Scully & Rosenfeld, 2002) . These cell types are defined by the particular hormones they produce, which in the anterior pituitary are the corticotrophs (adrenocorticotrophin secreting), somatotrophs (growth hormone), lactotrophs (prolactin), thyrotrophs (thyrotrophin), and gonadotrophs (luteinizing hormone and follicle-stimulating hormone), and in the intermediate lobes, the melanotrophs (melanocyte-stimulating hormone).
Molecular studies have demonstrated that Hh signaling is essential for the development of the hypothalamic-pituitary axis (M. M. Cohen, 2010; Treier et al., 2001) . In mice, SHH is expressed in the ventral diencephalon and the oral ectoderm and its downregulation triggers induction of the pituitary placode. A dual induction from the diencephalon is required for the formation of Rathke's pouch (Ericson et al., 1998; Takuma et al., 1998; Treier et al., 1998) , with both BMP4 and FGF signals from the ventral diencephalon being required for the development of a definitive pouch. Subsequently, a dorsoventral BMP2 gradient, appearing at a SHH boundary, together with an opposing dorsoventral FGF8 gradient, serve to determine ventral/intermediate cell phenotypes (gonadotropes, thyrotropes, somatotropes, lactotropes) and dorsal cell phenotypes (melanotropes and corticotropes), respectively, with attenuation of the BMP2 signal ultimately required for terminal differentiation. Shh null mice (Chiang et al., 1996) and mutations in human SHH or other SHH pathway interacting genes that cause HPE display pituitary agenesis (Odent et al., 1999; Roessler et al., 2003) . While this 4, 5, 7, 13, 15, 16, 20, 26-28, 33, 34, 37-41, 45, 50, 52, 53, 54 Anterior pituitary anomaly /hypopituitarism SHH, ZIC2, TGIF1, GLI2, PTCH1, 6, 9, 10, 12, 14, [16] [17] [18] [19] [20] [21] [22] [29] [30] [31] 34, 38, 47, 51, 52, 54 Short stature SHH, ZIC2, GLI2 4, 9, 10, 17, 18, 20, 33, 37, 42 Growth hormone deficiency GLI2, CDON 2, 4, 8, 9, 12, 18, 20, 28, 29, 38, 42 
| Adrenal gland
The adrenal gland contains a neuroendocrine medulla inside a steroidogenic cortex. The medulla produces catecholamines in response to sympathetic inputs, while the cortex produces essential steroids in response to hormonal inputs. Glucocorticoid release, which mediates the stress response (Sapolsky, Romero, & Munck, 2000) , is modulated by the hypothalamic-pituitary axis. During embryogenesis, the cortex develops from the intermediate mesoderm, but knowledge on cortical specification signals and development is scarce. The adrenal cortex originates from the adrenogenital primordium, a common gonadal and adrenal structure derived from the mesonephric mesenchyme and overlying celomic epithelium of the urogenital ridge (Hatano, Takakusu, Nomura, & Morohashi, 1996) . Some evidence suggests a role for Hh signaling: in situ hybridization experiments show that Shh mRNA is expressed in the outer adrenal cortex in mice, and human and murine models with Hh pathway mutations manifest adrenal aplasia or dysgenesis (Bitgood & McMahon, 1995; Ching & Vilain, 2009 ; P. J. King et al., 2008) . While these findings suggest a requirement for SHH in early adrenal development, adrenal dysgenesis can be the result of SHHmediated pituitary dysfunction as described above, which can cause loss of pro-opiomelanocortin (POMC)-derived pituitary hormones that are required for the trophic support of adrenal growth in postnatal life (Vila et al., 2005) . However, adrenal glands develop normally in POMC null mice (Karpac et al., 2006) , indicating that pituitary function is likely to affect adrenal development prenatally. In fact, the experiments of King, Paul, and Laufer (2009) demonstrate that SHH signaling has a direct effect on adrenocortical development at multiple levels, including modulation of capsule thickness and proliferation of steroidogenic cortical cells.
| Thyroid gland
During development, the foregut forms the esophagus, stomach, proximal duodenum, thymus, thyroid, airways, pancreas, and liver. Thyroid morphogenesis is initiated when the thyroid primordium buds from the ventral wall of the pharyngeal foregut endoderm that lies in close contact with the aortic sac endothelium (Alt et al., 2006; Fagman, Andersson, & Nilsson, 2006) . Interestingly, proper development of the thyroid requires exclusion of SHH expression (Fagman, Grande, Gritli-Linde, & Nilsson, 2004) . Although there is no SHH expression at any point in thyroid development, the thyroid does not separate into two distinct lobes in Shh 2/2 mice, and instead becomes a single unilateral mass (Fagman et al., 2004) . This single-lobe thyroid gland of Shh null mice forms normal follicles that contain apparently normally differentiating thyrocytes. In the study by Alt et al. (2006) , it was shown that this thyroid phenotype is indirectly caused by a failure of the aortic arch to cross the midline and both carotid arteries develop on one side of the esophagus.
As mentioned above, overexpression of SHH in the pituitary gland leads to pituitary hyperplasia by promoting proliferation and differentiation of the ventral pituitary cell types (gonadotrophs and thyrotrophs) (Treier et al., 2001 ). Additional investigation is needed to determine whether the thyroid dysfunction seen in some patients with HPE is a result of abnormal thyroid development or an indirect consequence of an aberrant hypothalamic-pituitary-thyroid axis.
| Organ systems
From the study of Gli mutant mice, it was apparent that the spectrum of defects observed remarkably resembled human VACTERL association (Quan & Smith, 1973) , which was originally given the VATER acronym to describe a number of associated malformations comprising vertebral defects (V), anal atresia (A), tracheoesophageal fistula with esophageal atresia (TE), radial, and renal dysplasia (R). The further observation of cardiac anomalies by Temtamy and Miller (1974) within a VATER cohort broadened the definition and the expanded acronym VACTERL was coined to also include limb defects (Kaufman, 1973; Nora & Nora, 1975) . Below, we describe the role of SHH signaling in the development of organ systems based on the phenotypic evaluation of Shh and Gli mutant mice.
| Skeletal system
SHH is secreted by the notochord and floor plate cells, which are involved in the patterning of the somites into the sclerotome and the dermamyotome. The sclerotome gives rise to the vertebral column and Reports of patients with a complex phenotype suggestive of chromosomal or syndromic HPE and without a molecular diagnosis were excluded. Gene names separated by a forward slash represent individuals with digenic mutations. a Genes currently reported as associated. New associations may be reported in the future.
the dermamyotome develops into muscle and skin (Christ, Huang, & Wilting, 2000) . In Shh 2/2 and Gli2 2/2 /Gli3 2/2 mice, lack of SHH signaling leads to severe disruption of the patterning of somites and results in a complete absence of the vertebral column (Chiang et al., 1996) .
More subtle defects in somite patterning were observed in the Gli2 and Gli3 mutant mice: the ventral and dorsal aspects of the vertebral column were defective in the Gli2 2/2 and Gli3 2/2 mice, respectively (Mo et al., 1997) . In the developing limb buds, SHH is expressed in a posterior region called the zone of polarizing activity, which is involved in limb patterning along the anteroposterior axis (Dudley & Tabin, 2000) . In Shh 2/2 mice, limb buds form initially, although most distal structures do not develop (Kraus, Fraidenraich, & Loomis, 2001; Mo et al., 1997) . In contrast, Gli3 2/2 and Gli2 2/2 /Gli3 2/2 limb buds develop extra digits, resulting in severe polydactyly (Mo et al., 1997) . In a more recent study, inhibition of the SHH pathway in rats using vismodegib (a drug for basal-cell carcinoma) showed a spectrum of malformations, including absent/fused digits in the hindlimb and unossified or incompletely ossified skeletal elements (Morinello, Pignatello, Villabruna, Goelzer, & Burgin, 2014 (Chiang et al., 1996) . These observations clearly illustrate the importance of gene dosage of Gli2 and Gli3 in SHH signaling during foregut development and suggest that defective SHH signaling can lead to a spectrum of foregut malformations commonly observed in human disease, including NCNS-HPE. Others have shown that Shh and Gli mutant mice also display distal hindgut defects (Kimmel et al., 2000; Mo et al., 2001 ) that represent the full spectrum of anorectal malformations observed in humans, including anal stenosis, imperforate anus, and cloaca. In Shh 2/2 mice, the distal hindgut fails to develop into separate alimentary and urinary tracts, resulting in a persistent cloaca (Mo et al., 2001 ).
These observations suggest that SHH signaling plays similar roles in epithelial-mesenchymal interactions underlying the development of the foregut and hindgut. Therefore, defects in this signaling pathway could be a molecular basis for the rarely associated gastrointestinal and respiratory malformations observed in NCNS-HPE.
| Cardiovascular system
SHH signaling participates in heart development. SHH is required for both cardiac progenitor specification and subsequent differentiation in Drosophila and in vertebrates, and is known to play a role in the specification of left-right asymmetry in early vertebrate embryogenesis (Ahmad, 2017) . Accordingly, Shh 2/2 mice display a variety of laterality defects including alteration of heart looping (Meyers & Martin, 1999; Tsukui et al., 1999) . The Gli2 2/2 /Gli3 2/2 mice exhibit persistent truncus arteriosus (Chiang et al., 1996) , one of the components of VACTERL association that may also manifest, although rarely, in NCNS-HPE. (Mo et al., 2001 ).
| Urogenital system
In addition to the systemic consequences of pituitary dysfunction as a result of brain maldevelopment, here we describe a spectrum of "below-the-neck" manifestations reported for NCNS-HPE, with a focus on studies involving large cohorts of patients. The findings of a comprehensive review of the literature are summarized in Table 1 . Reports of patients with a complex phenotype suggestive of chromosomal or syndromic HPE and without a molecular diagnosis were excluded.
| EN D OCR I NE D YSGE N ESI S I N N CN S-H P E
The first report of endocrine dysfunction in HPE dates back several decades. In 1961, two cases of alobar HPE were described that lacked a pituitary gland, and had hypoplasia of the adrenal cortex and the thyroid gland (Haworth, Medovy, & Lewis, 1961) . Over the years, additional clinical reports supported a relationship between NCNS-HPE and endocrinopathies, in particular posterior pituitary dysfunction, suggesting that the same midline defects implicated in the disease somehow affect the formation and function of the pituitary gland (Antonini, Grecco Filho, Elias, Moreira, & Castro, 2002; Hahn et al., 2005; Hintz, Menking, & Sotos, 1968; Traggiai & Stanhope, 2002) . Because the endocrine dysfunction associated with other glands (adrenal cortex, thyroid, gonads) are likely the result of pituitary insufficiency, our discussion below will focus on the latter.
As mentioned above, SHH signaling is essential for the development of the hypothalamic-pituitary axis (M. M. Cohen, 2010; Treier et al., 2001 ) and, thus, pathogenic mutations in HPE genes are expected to cause pituitary anomalies. Endocrine disorders were frequently reported in patients with solitary median maxillary central incisor (SMMCI) syndrome due to SHH mutations (MIM 147250), even before SMMCI was considered part of the HPE spectrum (Fulstow, 1968; Rappaport, Ulstrom, & Gorlin, 1976; Rappaport et al., 1977) . The molecular etiology for HPE-related endocrinopathies began to expand later when our group reported pituitary dysfunction associated with GLI2 mutations in patients with a distinctive HPE-like phenotype characterized by defective anterior pituitary formation and hypopituitarism, with or without apparent midline forebrain abnormalities (Roessler et al., 2003) . Several years later, França et al. (2010) (Table 1) .
| Posterior pituitary dysfunction
Posterior pituitary dysfunction seems to be the most frequently associated pituitary anomaly in HPE and manifests predominantly as diabetes insipidus (DI) (Hasegawa, Hasegawa, Yokoyama, Kotoh, & Tsuchiya, 1990; Traggiai & Stanhope, 2002; Van Gool et al., 1990) . Although, a formal meta-analysis has not been performed and many times reports
do not specify what pituitary hormones are deficient in HPE, the incidence of DI in HPE can be roughly estimated at 3-5% Lacbawan et al., 2009; Paulussen et al., 2010; Solomon et al., 2012) . Central DI is usually due to a midline structural abnormality that affects the hypothalamus or posterior pituitary gland, and results in vasopressin deficiency. In neuroimaging studies of classic HPE, the hypothalamic nuclei showed the highest incidence of nonseparation among the deep gray nuclei (Simon et al., 2000) , and the severity of DI was found to be correlated with the degree of hypothalamic nonseparation (Hahn et al., 2005) . However, there was no correlation between the severity of DI and an abnormality of the pituitary gland, suggesting that the deficiency in vasopressin secretion is somehow caused by a hypothalamic defect (Hahn et al., 2005) . One proposed mechanism of DI in HPE is an abnormal development of the supraoptic and paraventricular nuclei of the hypothalamus, or in the release of vasopressin via the infundibulum and the posterior pituitary gland (M. M. Cohen, 1989) . The defect in induction or patterning of the hypothalamic nuclei could cause a reduction in the number of vasopressin secretory neurons.
| Anterior pituitary dysfunction
Anterior pituitary dysfunction is less common in NCNS-HPE. Hahn et al. (2005) found in a cohort of 117 children with NCNS-HPE that 11% had hypothyroidism, 7% hypocorticism, 5% growth hormone deficiency, and 6% multiple pituitary hormone deficiency. These incidence values are lower than those reported by Traggiai and Stanhope (2002) , who found growth hormone deficiency in 42% and multiple pituitary hormone deficiency in 21% of their patients with HPE, possibly due to a selection bias as their patients were referred by an endocrinologist. In many clinical settings around the world patients with HPE do not undergo a comprehensive endocrine evaluation; therefore, the true incidence of endocrinopathies in NCNS-HPE is likely underestimated.
| SYST EM IC A N OM A LIE S I N NCN S-H P E

| Extracranial skeletal anomalies
Extracranial skeletal defects are frequent in NCNS-HPE. The overall spectrum of skeletal anomalies described across studies include scoliosis, costal, and/or vertebral abnormalities, radial dysplasia, talipes equinovarus, absent thumb, polydactyly, brachydactyly, clinodactyly, camptodactyly, and brachymetacarpalism. Our study of 157 NCNS-HPE patients with mutations in ZIC2 identified extracranial skeletal anomalies in 14% of patients , and the study of 645 NCNS-HPE probands and 699 relatives by Mercier et al. (2011) found defects in 16%, 9%, and 22% of patients with mutations in SHH, ZIC2, and SIX3, respectively. Mutational analysis of about 400 patients with NCNS-HPE spectrum identified 112 individuals with mutations in GLI2, of which those with truncating mutations were more likely to have pituitary anomalies and postaxial polydactyly (Bear et al., 2014) . A similar study of 110 patients with NCNS-HPE found three individuals with likely pathogenic GLI2 variants with associated postaxial polydactyly (Bertolacini, Ribeiro-Bicudo, Petrin, Richieri-Costa, & Murray, 2012) . Because many mutations in GLI2 do not result in frank HPE but instead are associated with specific findings including pituitary insufficiency and/or polydactyly, this phenotype was recognized as CullerJones syndrome (MIM 615849). Recently, our group published a study of adolescents and adults with NCNS-HPE that proposed an expansion of the NCNS-HPE phenotype to include clinical manifestations not typically considered as part of the spectrum. In that study, one patient with NCNS-HPE and negative four-gene screening results presented with scoliosis, hemivertebrae, and missing ribs (Weiss et al., 2018) .
| Spinal neural tube defects
The study by Mercier et al. (2011) of 645 NCNS-HPE probands and 699 relatives found neural tube defects (NTDs) in 4% and 8% of individuals more frequently associated with ZIC2 (rachischisis) and TGIF1 mutations, respectively. However, no overall statistical correlation was found between NTDs and the molecular data. Similarly, we reported an incidence of NTDs of 4% in a cohort of 157 NCNS-HPE patients with mutations in ZIC2 . Interestingly, an association between a histidine track polymorphism in ZIC2 and NTDs had been previously proposed (L. Y. Brown et al., 2002) , although a causal effect has not been demonstrated. Functional studies in a murine model of Zic2 downregulation showed delayed neurulation resulting in HPE,
| 251 spina bifida and skeletal abnormalities (Nagai et al., 2000) . While the mechanisms by which ZIC2 mutations cause NTDs are not well understood, they are thought to be associated with the role of this gene in axial midline establishment during early development, even before it appears to influence the development of the dorsal telencephalon (Cheng et al., 2006; Warr et al., 2008) .
Other reports have shown an association between spinal NTDs and mutations in SHH and SIX3 Paulussen et al., 2010) .
| Congenital heart anomalies
Congenital heart defects have been reported in NCNS-HPE patients with SHH (8%), ZIC2 (14%) and TGIF1 (25%) mutations . To the best of our knowledge, there has been only one single report of cardiac anomaly, in particular a septal defect, associated with SIX3 mutations (Poelmans et al., 2015) . Also, we found in our study of 157 probands with ZIC2-associated HPE that 9% had a cardiac anomaly . A mutant Zic2 mouse model has shown association with random cardiac situs and demonstrated that this gene is required for left-right axis formation, likely because of its role controlling the expression of genes driving the formation and function of node cilia (Barratt, Glanville-Jones, & Arkell, 2014) . We have previously suggested a link among NODAL signaling, heart anomalies, and NCNS-HPE, but to date there have been no reports of patients with mutations affecting this pathway that have both HPE and a congenital heart defect (Karkera et al., 2007; Roessler, Pei, et al., 2009; Roessler et al., 2008) . However interesting, a recent work has demonstrated that ZIC2 mutations cause HPE by disrupting NODAL signaling (Houtmeyers et al., 2016) .
| Other congenital visceral anomalies
Visceral defects involving the gastrointestinal, respiratory, and genitourinary systems may occur in NCNS-HPE. Some of the studies mentioned above have described malformations in these systems in patients with NCNS-HPE with identifiable mutations (Bear et al., 2014; Dubourg et al., 2004; Mercier et al., 2011; Paulussen et al., 2010; Solomon et al., 2010 Solomon et al., , 2012 Weiss et al., 2018) . For example, a significant correlation was found between renal/urinary malformations and mutations in SHH and ZIC2 . In our study of 396 individuals with mutations in SHH, 5% had genitourinary/renal abnormalities including hypoplastic penis, cryptorchidism, renal hypoplasia, hypospadias, and ambiguous genitalia (Solomon et al., 2012) .
| Fatty liver disease
Nonalcoholic fatty liver disease (NAFLD) was only recently proposed by our group to be part of the HPE spectrum (Guillen-Sacoto et al., 2017) .
The role of SHH signaling in liver homeostasis has long been established, with vast evidence supporting activation of the pathway during acute and chronic liver injury (Machado & Diehl, 2018) . Elicited tissue responses to SHH ligand include expansion of liver progenitor populations, myofibroblast accumulation and fibrogenesis, repairassociated inflammation, and vascular remodeling (Machado & Diehl, 2018) . In addition to its role in liver repair, several animal studies have suggested an involvement of SHH signaling in the regulation of lipid metabolism in adipocytes (Moisan et al., 2015; Suh et al., 2006 ) and more recently, in hepatocytes (Matz-Soja et al., 2016) . However, the effect of germline SHH pathway mutations on the development and progression of NAFLD in humans had not been investigated. Analysis of a large pediatric and adult NCNS-HPE cohort revealed a significant association between HPE and liver steatosis that was independent of the severity of brain malformation, demographic characteristics, obesity or hepatotoxic influences such as special diets, alcohol, or medications (Guillen-Sacoto et al., 2017) . This observation was recapitulated in a Gli2 heterozygous null mouse model of diet-induced fatty liver disease that showed increased liver steatosis with reduced or absent fibrosis and inflammation when compared to wildtype animals (Guillen-Sacoto et al., 2017) . While this finding may appear counterintuitive based on the established paradigm of NAFLD progression otherwise involving upregulation of fibrosis and inflammation (Cai et al., 2016) , the long-term effects of liver steatosis in the context of Hh signaling attenuation are unknown and, therefore, patients with HPE and their mutation-positive relatives must be followed up for NAFLD-associated health risks.
| SU M M A RY
While NCNS-HPE has traditionally been considered as an "above-theneck" condition primarily involving forebrain and craniofacial structures, substantial clinical evidence supports an association between mutations in NCNS-HPE genes and congenital anomalies affecting various organ systems. HPE must be considered as a complex Mendelian disorder in terms of both clinical presentation and molecular etiology that is determined by an intricate network of interacting genetic and environmental factors. It has been suggested that NCNS-HPE involves a multiple-hit process Rosenfeld et al., 2010 ) and animal models have provided evidence supporting at least possible digenic mechanisms that implicate either the same or two different signaling pathways. This hypothesis is supported by observations of low penetrance and/or variable expressivity in NCNS-HPE multiplex families and reports of patients with two different mutations Nanni et al., 1999; Rahimov, Ribeiro, de Miranda, Richieri-Costa, & Murray, 2006; Wannasilp et al., 2011) . To better understand the pathophysiology of the broader NCNS-HPE spectrum, it is critical to perform a thorough evaluation of probands and their relatives to include extracephalic manifestations, especially in mildly affected individuals. Because of the complex interaction between Hh signaling and other developmental pathways, and the incomplete penetrance and variable expressivity associated with many pathogenic variants, it is possible that a proportion of patients with NCNS-HPE belong to different diagnostic labels of known syndromes or yet unidentified ones. A better understanding of the molecular effects of HPE-associated mutations and the identification of modifier genes will help us to dissect the complex pathogenesis of NCNS-HPE and related disorders. It is our ultimate goal to directly translate research findings into better care for affected patients and their families.
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